ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000224745.1	Motesanib	Skin cutaneous melanoma	0.013561934	Resistant
ENSG00000224745.1	Motesanib	Stomach adenocarcinoma	0.036347174	Resistant